Sintx Technologies Inc.
SINTX Technologies (NASDAQ: SINT) leads in developing new applications for advanced ceramic materials.
Nasdaq: SINT
IR Website: https://ir.sintx.com/
Headquarters: Salt Lake City, UT
Content provided by Sintx Technologies Inc. on 3-3-22.
TALK TO MANAGEMENT
The Sintx Technologies Inc. management team is always available to talk to current and potential investors. They're happy to answer any questions you may have and tell you what makes their story unique. Please fill out this form, and we will connect you shortly.
Summary
SINTX Technologies (NASDAQ: SINT) leads in developing new applications for advanced ceramic materials:
1. Our silicon nitride spinal fusion implants are FDA-approved; with faster bone healing, bacterial resistance, and ease of radiographic imaging
2. Our new SINTX Armor facility is positioned to supply ceramic armor plates to protect armed forces and law enforcement against ballistic threats
3. Our silicon nitride impregnated fabric technology is a catch-and-kill solution to microbes such as viruses, bacteria, and fungi
4. Our polymer composites and coating technologies based on silicon nitride have wide applications in medical devices, aerospace, defense, and many industrial applications
Investor Presentation
Recent News
SINTX Announces Milestones In The Development and Testing of Antipathogenic Fabrics
Feb 23, 2022
SINTX Chief Scientific Officer Retires and Director of R&D Steps Into Leadership Role
Dec 31, 2021
SINTX Technologies Provides End of Year 2021 Business Update
Dec 8, 2021
SINTX Technologies Provides Update on SINTX Armor
Nov 16, 2021
SINTX Technologies Ends Patent License Agreement With O2TODAY
Nov 5, 2021
Management Overview
B. Sonny Bal, MD, JD, MBA, PhD
Chief Executive Officer, President, Chairman of the Board & Principal Financial Officer
Dr. Sonny Bal has served on the Board of Directors of SINTX Technologies since February 2012, and as Chairman of the Board since August 2014. In October 2014, he was appointed the CEO & President of SINTX Technologies.
Dr. Bal previously served as Professor of Orthopaedic Surgery and Adjunct Professor of Material Sciences at the University of Missouri. He has >20 years of clinical experience as an orthopaedic surgeon and attorney, and is affiliated with several professional organizations. In addition to serving on the editorial boards of peer-refereed journals, Dr. Bal has researched and published extensively in ceramic science, and continues that work.
Dr. Bal holds an M.D. from Cornell University, an M.B.A. from Northwestern University, a J.D. from the University of Missouri and a Ph.D in Materials Engineering from the Kyoto Institute of Technology.
David O'Brien
Chief Operating Officer
Mr. O’Brien previously served as the Company’s Vice President and General Manager from October 2016 to July 2019. From March 2014 through September 2016, he was SINTX Technologies’ Vice President of Operations and Vice President of Manufacturing.
Mr. O’Brien has over 30 years of experience in engineering, manufacturing, and operations leadership in advanced materials and medical device organizations. From 2005 to 2014, he fulfilled several engineering leadership roles for Covidien including Manufacturing Engineering Manager for the Norfolk, Nebraska facility. From 1991 to 2005, he worked for Arnold Magnetic Technologies in the production of ceramic, powder metal, and molded magnets in multiple facilities across the U.S. and in England.
He has extensive experience with Lean and other Continuous Improvement initiatives. Mr. O’Brien holds an M.S. in Ceramic Engineering from the Georgia Institute of Technology and a B.S. in Physics from the University of Texas at San Antonio.
Ryan Bock, PhD
Vice President of Research & Development
Dr. Bock has more than 20 years of experience in advanced ceramic research and development. Since joining SINTX 2008, he has participated in and led process and material development efforts for SINTX’s silicon nitride and subsequent discoveries of silicon nitride’s antipathogenic and biologic properties. Prior to joining SINTX, Dr. Bock was a researcher at the University of California at Santa Barbara, where he developed novel slurry systems for use in colloidal processing of advanced ceramic materials.
Dr. Bock is a co-author of more than 20 peer-reviewed technical papers in subject areas of ceramic science and biomaterials science. He served as a symposium organizer for the Surface Properties of Biomaterials Symposium at the annual Materials Science & Technology technical meeting from 2016 through 2019.
Dr. Bock holds a B.S. in Materials Science and Engineering from the University of Florida and a Ph.D. in Biomaterials from the Kyoto Institute of Technology.
Donald J. Bray
Vice President of Business Development (Armor and Industrial Markets)
Mr. Bray has more than 30 years of experience in the technology and business of advanced ceramics. Prior to joining SINTX, Mr. Bray held various senior roles in notable ceramics and materials companies, including Alcoa, Advanced Refractory Technologies, Poco Graphite, and Morgan Advanced Materials.
Mr. Bray holds B.S. and M.S. degrees in Materials Science and Engineering from Iowa State University, and an EMBA from the University of Texas – Dallas.
Michael Marcroft
Vice President of Business Development (Medical Technology Market)
Mr. Marcroft will lead business development initiatives within the medical device sector. With nearly two decades of experience in medical technology business development & marketing, Mr. Marcroft has previously held positions at 3M, Medtronic, and Boston Scientific. He most recently served as Vice President of Marketing at Vision Source, where he led several key initiatives.
Joseph Palomo
Vice President of Business Development (Antipathogenic Market)
Mr. Palomo has more than 40 years of medical device development and manufacturing experience in protective apparel and other medical products: surgical gowns, surgical drapes, isolation gowns, films, tubing and medical face masks. Instrumental in development of performance standards for medical devices in ASTM and AAMI. Has held management roles in Cardinal Health R&D for new product development on a global scale with Latin America and Asia.
He holds a BS degree in Mechanical Engineering from Illinois Institute of Technology.
Risks & Disclosures
This communication is neither an offer to sell nor a solicitation of an offer to buy, nor a recommendation of any securities of the company mentioned herein.
Sintx Technologies Inc. (the “Company”) and its counsel have reviewed the content of this page as well as the accompanying presentation (“Company Presentation”) displayed on this page. To the best of its knowledge, the Company does not believe this content to be misleading or inaccurate in any material respect, nor does it believe there are any material omissions with respect to such content. The Company does not believe the contents of the page or the Company Presentation to contain any non-public material information.
Information and opinions presented in the Company Presentation are provided by the Company, and b2i digital makes no representation as to their accuracy or completeness. The information contained on this page is not intended to constitute any form of advice, and the information provided is not intended to provide a sufficient basis on which to make an investment decision. It is not investment research, nor does it constitute a research recommendation, as it does not constitute substantive research or analysis. This information is not to be relied upon in substitution for the exercise of independent judgment.
Information, opinions and estimates contained on this page or in the Company Presentation reflect judgments by the Company as of the original date of publication by the Company and are subject to change without notice. Past performance should not be taken as an indication or guarantee of future performance, and no representation or warranty, express or implied is made regarding future performance.
A complete description of the risks and uncertainties relating to the Company and its securities can be found in the company's filings with the U.S. Securities and Exchange Commission available for free at www.sec.gov.
Information on this page may relate to penny stocks, which may also be referred to as low-priced stocks. Penny stocks are low-priced shares typically issued by small companies. Penny stocks involve greater than normal risk, they may be less liquid than other stocks (i.e., more difficult to sell), and there may be less reliable information available regarding such stocks. Investors in penny stocks should be prepared for the possibility that they may lose their entire investment.
B2I DIGITAL, Inc. is a marketing sponsor of the Roth 34th Annual Roth Conference. B2I DIGITAL, Inc. is not an affiliate of Roth Capital Partners, LLC (“Roth”) and is not authorized to represent or act on behalf of Roth ,in any capacity. Roth has not reviewed and approved the content contained on the b2idigital.com website.
